Search results for: 'data 01'

This study encompasses vital feedback provided by outsourcing decision makers within pharmaceutical and biotechnology companies allowing CROs to gain insight into current and future outsourcing patterns and trends. Through the analysis provided, CROs will better be able to understand motives and perceived benefits of outsourcing, criteria for CRO s...

This research service provides insights about the U.S. chemical biological and nuclear detection market.

This Research Service analyzes market trends in the United States high acuity information systems market since 2004, forecasts future changes in market measurements through 2012, and discusses specific challenges facing industry participants and strategic recommendations targeted to overcome these challenges. The high acuity care information system...

This study covers the current water and wastewater scenario, trends, opportunities, news and events in northeast United States.

The U.S. Multiple Myeloma Market is a rapidly progressing field that is set to generate over $3 billion in revenue in the coming years. The market has witnessed unprecedented growth with the launch of three new drugs. The dynamics of this market are changing rapidly and the forecast through 2013 highlights the major changes. This study includes ...

This study examines the market and market participants involved in the U.S. Atherectomy and Thrombectomy Devices Market.

The World Drug Discovery Technologies market is a dynamic marketplace with substantial opportunity. This study focuses on the market dynamics of 2005, by looking at the four major contributors to this market: top 20 pharmaceutical companies, biotechnology companies, top 5 agribiotech companies, and the NIH budget. The study also provides detailed ...

This research study examines the disposable medical gloves markets in the U.S. in 2005. The objective of this study is to evaluate the present state of these markets and present a forecast and analysis of the units, pricing and revenues. The forecast period is from 2006 to 2010, with a base year of 2005. The segment also identifies the key challen...

The U.S. Alzheimer's disease medication markets research service provides revenue and patient forecasts, competitive analysis, market trends, product analysis and strategies for growth. The market is segmented by product type into cholinesterase inhibitors, NMDA receptor antagonists and new mechanism drugs. Each of the segments discusses in detail ...